Pinned
🎉 Online first: After positive press release of IMforte trial, our timely published review of the MoA of #lurbinectedin and its implications for combinational therapies in #SCLC, including immunotherapy. #LCSM 🫁
Check it out here 👉aacrjournals.org/mct/article/do…






